Kennedy Institute of Rheumatology secures five-year major funding from the Kennedy Trust for Rheumatology Research
This substantial investment will enable the Institute to continue its world-leading research into the fundamental causes of inflammatory and musculoskeletal diseases, while accelerating the development of new and improved therapies.The funding will underpin KIR's distinctive discovery-to-translation pipeline, an approach that integrates fundamental scientific discovery with clinical application. This unique model enables researchers to translate insights from basic biology into innovative treatments for conditions including arthritis, fibrosis and inflammatory bowel disease.Over…

